CARM

Carisma Therapeutics
CARM

Delisted

CARM was delisted on the 10th of October, 2025.

27 hedge funds and large institutions have $5.26M invested in Carisma Therapeutics in 2017 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 10 increasing their positions, 2 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.04% less ownership

Funds ownership: 0.52%0.48% (-0.04%)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $37K

Holders
27
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
$37K
Net Calls
Net Calls Change

Top Buyers

1 +$979K
2 +$207K
3 +$143K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$120K
5
Citadel Advisors
Citadel Advisors
Florida
+$65K

Top Sellers

1 -$343K
2 -$268K
3 -$102K
4
VKH
Virtu KCG Holdings
New York
-$56K
5
AL
Airain Ltd
Guernsey
-$48K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$1K
27
$1K
28
29
30
31
32
33